Syndax Pharmaceuticals

+$0.53 (+3.62%) Today
$0.00 (0.00%) As of 8:01 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352.

CEO
Michael A. Metzger
Employees
59
Headquarters
Waltham, Massachusetts
Founded
2005

SNDX Key Statistics

Market cap
853.61M
Price-Earnings ratio
39.35
Dividend yield
—
Average volume
459.97K
High today
$15.38
Low today
$14.55
Open price
$14.55
Volume
325.73K
52 Week high
$22.71
52 Week low
$13.27

SNDX Earnings

-$0.71
$0.13
$0.97
$1.81
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure